Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

123.49
Delayed Data
As of Aug 22
 +8.65 / +7.53%
Today’s Change
92.56
Today|||52-Week Range
141.86
+26.84%
Year-to-Date

Today’s Trading

Previous close114.84
Today’s open115.16
Day’s range112.57 - 125.52
Volume7,289,754
Average volume (3 months)1,721,467
Market cap$24.9B
Data as of 4:00pm ET, 08/22/2019

Growth & Valuation

Earnings growth (last year)-82.40%
Earnings growth (this year)+25.14%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+17.00%
P/E ratio20.8
Price/Sales5.29
Price/Book2.70

Competitors

 Today’s
change
Today’s
% change
REGNRegeneron Pharmaceut...-2.76-0.93%
INCYIncyte Corp-0.51-0.59%
SGENSeattle Genetics Inc-1.61-2.01%
IONSIonis Pharmaceutical...-4.30-5.96%
Data as of 4:00pm ET, 08/22/2019

Financials

Next reporting dateOctober 28, 2019
EPS forecast (this quarter)$2.47
Annual revenue (last year)$4.1B
Annual profit (last year)$77.6M
Net profit margin1.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Boston, Massachusetts

Forecasts